LAKE FOREST, CA--(MARKET WIRE)--Apr 18, 2008 -- CryoPort, Inc. (OTC BB:CYRX.OB - News), a company developing leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain, today announced that the company has been added as a component of the Ludlow Biotech Index http://www.ludlowcapital.com/indices/biotech/historic/.

"We are pleased to include CryoPort, Inc. in the Ludlow Biotech Index," stated Thomas J. Latino, PhD, head of equity research at Ludlow BioVentures, Inc. "CYRX's successful international shipment of clinical samples on behalf of Quest Diagnostics proves the company has completed a successful transition from a early stage developmental company to one that is a commercial enterprise with a growing base of clients. Ludlow BioVentures believes CryoPort will continue to expand the market for its CryoPort Express™ Shipper system throughout 2008 and this makes CYRX an attractive addition to our index."

About Ludlow Biotech Index

The Ludlow Biotech Index tracks a basket of top US traded biotechnology stocks. The Index provides both institutional and individual investors a gauge for tracking the day-to-day performance of the biotechnology sector. The index is designed for investors who have a long-term bullish outlook on the biotech market. The Ludlow Biotech Index is owned and operated by Ludlow BioVentures, Inc., based in New York City. www.ludlowcapital.com/bioventures/

About CryoPort, Inc.

CryoPort (www.cryoport.com) develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

     Contact:
     Stuart Fine
     Carpe DM, Inc.
     908-469-1788
      
     Thomas Latino, PhD
     Ludlow BioVentures
     Phone: (201) 245-4278
     Email: tlatino@ludlowcapital.com